DIGESTION BALLONNEMENTS BIEN-ÊTRE
Food supplement declared in France, decision dated 15 September 2025
DIGESTION BALLONNEMENTS BIEN-ÊTRE (GLOWII) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Hordeum vulgare 1,110 mg per day, Brassica oleracea 560 mg per day, Euterpe oleracea 333 mg per day, Vitis vinifera 333 mg per day, Moringa oleifera 170 mg per day. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- GLOWII
- Food business operator placing the product on the market
- 1108 BRANDS
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Powder
- Daily dose
- 10 g
- Directions for use
- 1 à 2 doses par jour . Mélanger dans environ 230 ml d'eau.
- Intended populations
- General population, Men and women aged 18 and over, People over 60
- Not recommended (according to the manufacturer)
- Breastfeeding women, Pregnant women, Taking thyroid medication
- Objectives stated by the manufacturer (these are not authorised claims)
- Bowel regularity, Digestion
- Flavourings
- Mangue
Declaration 340178, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Hordeum vulgare L. | Jeune pousse | Poudre (de plantes séchées ou broyées) | 1,110 mg |
| Brassica oleracea var. italica | Parties aériennes | Poudre (de plantes séchées ou broyées) | 560 mg |
| Euterpe oleracea Mart. | Fruit | Poudre (de plantes séchées ou broyées) | 333 mg |
| Vitis vinifera L. | Pépin | Extrait sec hydroalcoolique | 333 mg |
| Moringa oleifera Lam. | Feuille | Extrait sec aqueux | 170 mg |
| Withania somnifera (L.) Dunal | Racine | Extrait sec alcoolique | 50 mg |
Other active ingredients
| Name | Per day |
|---|---|
| dextrine | not declared |
| Inuline | not declared |
| Fibres de pomme | not declared |
Additives
E551, E955, E415, E968, E330
Other ingredients
Spinacia oleracea L., Chlorella vulgaris Beijerinck, Adansonia digitata L., Spirulina platensis (Gomont) Geitler, Rosa canina L.
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
Réservé aux adultes Déconseillé aux femmes enceintes et allaitantes Une consommation excessive peut avoir des effets laxatifs Déconseillé aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin
Regulatory points
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Euterpe oleracea Mart.
Read the warning, when it applies and the studies cited
ACAI – EUTERPE OLERACEA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (derMarderosian and Beutler 2008).
Sources cited by Health Canada (1)
- derMarderosian A, Beutler JA, editors. The Review of Natural Products. [Acai: Date of issue January 2008]. St Louis (MO): Facts and Comparisons, Wolters Kluwer Health; Printed in 2008 and Updated to April 2012.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (derMarderosian and Beutler 2008).
Sources cited by Health Canada (1)
- derMarderosian A, Beutler JA, editors. The Review of Natural Products. [Acai: Date of issue January 2008]. St Louis (MO): Facts and Comparisons, Wolters Kluwer Health; Printed in 2008 and Updated to April 2012.
- Withania somnifera (L.) Dunal
Read the warning, when it applies and the studies cited
ASHWAGANDHA - WITHANIA SOMNIFERA
Route of administration: Oral
Cautions and warnings
Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).
Sources cited by Health Canada (3)
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press, LLC; 1997.
- Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz (CA): American Herbal Pharmacopoeia; 2000.
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze K, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC) : American Pharmaceutical Association; 2002.
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).
Sources cited by Health Canada (3)
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA and Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- McGuffin M, Hobbs C, Upton R, Goldberg A, éditeurs. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL) : CRC Press, LLC; 1997.
- Upton R, éditeur. Ashwagandha Root, Withania somnifera Analytical, Quality Control, And Therapeutic Monograph. Santa Cruz (CA) : American Herbal Pharmacopoeia and Therapeutic Compendium; 2000.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- DIGESTION BALLONNEMENTS BIEN-ÊTRE GLOWII, declared in 2025 : different composition: 4 ingredient(s) added, 4 missing
- DIGESTION BALLONNEMENTS BIEN-ÊTRE GLOWII, declared in 2025 : different composition: 4 ingredient(s) added, 4 missing
- DIGESTION BALLONNEMENTS BIEN-ÊTRE GLOWII, declared in 2025 : same declared composition
Brand : GLOWII
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “DIGESTION BALLONNEMENTS BIEN-ÊTRE (GLOWII): composition and regulation”, https://compoatlas.com/en/supplements/products/340178-digestion-ballonnements-bien-etre, updated 15 November 2026.